🌿 Trusted by 500+ brands globally  ·  +49 157 813 937 56  ·  enquiry@ingexgermany.de
Joint Health, Mobility & Vitality

Clinically Proven Joint Comfort & Mobility

Boswegex® is a clinically proven Boswellia extract for joint health, anti-inflammatory support, healthy aging and mobility. Clinically validated for sustained joint comfort and an active lifestyle.

Request a Sample View Clinical Study
About the Ingredient

Boswegex®, A Clinically Proven Boswellia Extract

Boswegex® is a premium, full-spectrum Boswellia extract made from the resin of Boswellia serrata, one of the most respected botanicals for joint health. It is developed and manufactured by Ingex Botanicals (P) Limited, India, the manufacturing arm of Ingex Germany GmbH, and supplied to nutraceutical and supplement companies across Europe.

Boswegex® outperforms standard Boswellia extracts by preserving beyond six boswellic acids. Unlike isolates, it retains the complete molecular fingerprint of Boswellia for enhanced biological activity. Manufactured using patented green manufacturing technology and verified by HPLC, this premium extract delivers sustained analgesic and anti-inflammatory effects.

Whether you are developing joint comfort capsules, mobility tablets, or active lifestyle formulations, Boswegex® gives your product a clinically validated, science-backed foundation.

Request a Sample View Specifications
Boswellia serrata resin, the source of Boswegex Boswellia Extract
NSF · ISO · GMP
Kosher & HALAL Certified
Quick Overview

Boswegex® at a Glance

Everything you need to know about this clinically proven full-spectrum Boswellia ingredient. Origin, the full-spectrum advantage, clinical evidence, and certifications.

01 / Origin

Origin & Source

Boswegex® is derived from the resin of Boswellia serrata, also known as Indian frankincense, one of the most established botanicals in traditional joint health. This heritage is brought into modern nutraceutical science as a standardised, clinically validated extract.

02 / The Advantage

Full-Spectrum Profile

Boswegex® preserves beyond six boswellic acids, retaining the complete molecular fingerprint of Boswellia. Unlike single-compound isolates, this full-spectrum approach delivers enhanced biological activity and sustained efficacy.

03 / Science

Clinical Evidence

Backed by a 3-month, 100-subject randomized, double-blind study (CTRI/2025/03/081512). At 600mg daily, KOOS pain reduced 38.08% and WOMAC stiffness 34.31%, with reduced CRP, IL-6 and TNF-alpha.

04 / Quality

Certifications

Produced in a 100% solar-powered facility certified for NSF-GMP, HACCP, and ISO 9001. Boswegex® is also Kosher and HALAL certified, manufactured with patented green technology and HPLC verified.

Our Strategic Edge

Four Foundations Behind Boswegex®

What sets us apart, a full-spectrum efficacy profile, robust clinical validation, green manufacturing, and HPLC-verified consistency.

Full-Spectrum Efficacy

Beyond Six Boswellic Acids

Retains the complete molecular fingerprint of Boswellia

Clinically Validated

CTRI-Registered Trial

3-month, 100-subject randomized, double-blind study

Green Manufacturing

100% Solar-Powered

Patented green technology for a de-risked, eco-friendly supply

HPLC Verified

Batch-to-Batch Consistency

Analytically verified for reliable, standardised potency
Why Choose Boswegex®

Boswellia Extract Manufacturers & Suppliers in Europe You Can Trust

From clinically proven full-spectrum efficacy and green manufacturing to Rotterdam warehouse stock and complete EU documentation, Boswegex® is built for European B2B nutraceutical brands.

Why Brands Choose Boswegex®

  • Full-spectrum Boswellia serrata, beyond six boswellic acids
  • Clinically validated by a CTRI-registered double-blind trial
  • Patented green manufacturing technology
  • NSF-GMP, HACCP, and ISO 9001 certified facility
  • Kosher and HALAL certified, EU market ready
  • EU warehouse in Rotterdam, fast delivery across Europe
  • HPLC verified for batch-to-batch consistency
  • Full batch documentation: CoA, SDS, regulatory support
  • Solar-powered, de-risked and eco-friendly supply chain

Health Benefits of Boswellia

  • Joint health: Clinically proven joint comfort and mobility support
  • Anti-inflammatory: Reduces key markers, CRP, IL-6 and TNF-alpha
  • Healthy aging: Supports an active lifestyle through the years
  • Mobility & vitality: Improves joint flexibility and reduces stiffness
  • Quality of life: Sustained, long-term relief from joint discomfort

Why Full-Spectrum Boswellia Matters

  • Retains the complete boswellic acid profile, not a single isolate
  • Enhanced biological activity from synergistic compounds
  • Delivers sustained analgesic and anti-inflammatory effects
  • Ideal for joint comfort and active lifestyle formulations

Clinically Proven Joint Mobility

Boswegex® outperforms standard Boswellia extracts by preserving beyond six boswellic acids. Manufactured using patented green manufacturing technology and verified by HPLC, this premium extract delivers sustained analgesic and anti-inflammatory effects.

This makes Boswegex® the ideal choice for joint comfort and active lifestyle formulations, giving your brand a clinically validated, full-spectrum joint health credential.

EU Warehouse, Rotterdam, Netherlands

As dedicated Boswellia extract suppliers in Europe, we hold stock at our Rotterdam warehouse for fast, reliable delivery across the EU. No long lead times. Your order ships from the Netherlands.

Get a Quote
Product Specifications

Available Grades & Specifications

Boswegex® full-spectrum Boswellia extract is supplied in a range of standardised grades and forms to meet the precise requirements of European supplement, joint health and mobility formulations. Custom specifications available on request.

Grade / Form Standardisation Typical Application
Boswellic Acids 30% to 80% by Titrimetry Capsules, tablets, joint comfort & mobility supplements
Boswellic Acids up to 20% by HPLC Standardised low-dose joint health blends
AKBBA 10% to 60% by HPLC High-potency, clinical-grade joint & mobility applications
Granules — AKBBA 10% to 80% by HPLC Direct compression tablets, capsules, sachets
Granules — Boswellic Acids 20% to 70% by Titrimetry Direct compression tablets, capsules, premixes
Granules — Boswellic Acids 80% & 85% by HPLC Premium high-potency tablets and capsules
Boswellia serrata Extract 65% HBD Functional beverages, gummies, liquid formats
Custom Grade Available on Request Bespoke to customer formulation specifications

Custom specifications can be developed on request. Contact us for certificates of analysis, safety data sheets, and technical documentation.

Request a Specification Quote Request COA & SDS
Evidence-Based

Clinical Study

Boswegex® is supported by a randomized, double-blind, placebo-controlled clinical trial registered with the Clinical Trials Registry of India.

CTRI-Registered Trial

A 90-Day Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Boswegex® on Joint Pain, Stiffness & Inflammatory Markers

CTRI Registry No: CTRI/2025/03/081512 · 100 subjects · 3 months · 600 mg/day

A prospective, randomized, double-blind, placebo-controlled clinical trial conducted on 100 subjects over 3 months (90 days) with a daily dose of 600 mg of Boswegex®.

The study measured the KOOS Pain Sub Score and WOMAC stiffness index at Day 0, 30, 60 and 90, alongside key inflammatory markers, CRP, IL-6 and TNF-alpha.

Request Full Study Summary

Key Study Findings

KOOS Pain Score

KOOS pain score in Boswegex® and placebo, Day 0, 30, 60 and 90

Bar chart showing KOOS Pain Score comparing Boswegex and placebo at Day 0, 30, 60 and 90 60 55 50 45 40 KOOS Pain Day 0 40.57 40.96 Day 30 44.39 41.13 Day 60 49.48 41.67 Day 90 56.02 42.26 Higher KOOS score indicates greater pain relief
Boswegex®
Placebo

WOMAC Stiffness

WOMAC stiffness in Boswegex® and placebo, Day 0, 30, 60 and 90

Bar chart showing WOMAC stiffness comparing Boswegex and placebo at Day 0, 30, 60 and 90 7 6 5 4 3 WOMAC Day 0 5.48 5.34 Day 30 5.25 5.32 Day 60 4.27 4.94 Day 90 3.60 4.34 Lower WOMAC score indicates reduced joint stiffness
Boswegex®
Placebo

PrimaryClinical Proof, 90 Days at 600 mg/day

  • 38.08% reduction in KOOS Pain Sub Score, long-term relief
  • 34.31% reduction in WOMAC stiffness, enhanced joint mobility
  • Significant improvement in joint flexibility and comfort

SecondaryInflammatory Support

  • Clinically proven reduction in CRP
  • Clinically proven reduction in IL-6
  • Clinically proven reduction in TNF-alpha
Boswegex® is clinically proven to deliver sustained joint comfort, improved mobility and meaningful anti-inflammatory support over a 90-day course.
Need Help?

Frequently Asked Questions

Common questions from nutraceutical and supplement brands in Europe about Boswegex® Boswellia extract.

What is Boswellia extract?
Boswellia extract is a botanical extract derived from the resin of the Boswellia serrata tree, also known as Indian frankincense. It is one of the most respected botanicals for joint health, valued for its boswellic acids, which support anti-inflammatory activity, joint comfort and mobility. It is widely used in joint health supplements across Europe and globally.
What makes Boswegex® a full-spectrum Boswellia extract?
Unlike isolates that focus on a single compound, Boswegex® preserves beyond six boswellic acids, retaining the complete molecular fingerprint of Boswellia serrata. This full-spectrum profile delivers enhanced biological activity, providing sustained analgesic and anti-inflammatory effects that single-compound isolates cannot replicate. It is manufactured using patented green technology and verified by HPLC for consistency.
Is Boswegex® clinically studied?
Yes. Boswegex® is backed by a 3-month, 100-subject randomized, double-blind clinical study (CTRI/2025/03/081512). After 90 days at a 600mg daily dose, the KOOS Pain Sub Score decreased by 38.08%, demonstrating long-term relief, and WOMAC stiffness reduced by 34.31%, significantly enhancing joint mobility. The study also showed a clinically proven reduction in key inflammatory markers, CRP, IL-6 and TNF-alpha. Contact us to request the full study summary.
What are the main health benefits of Boswellia?
The key health benefits of Boswellia include support for joint health and joint comfort, anti-inflammatory activity through the reduction of key markers such as CRP, IL-6 and TNF-alpha, improved mobility and flexibility with reduced joint stiffness, support for healthy aging and an active lifestyle, and an overall improvement in quality of life. These benefits make Boswellia a cornerstone ingredient for joint health supplements.
What is the recommended dose used in the clinical study?
The Boswegex® clinical trial (CTRI/2025/03/081512) used a daily dose of 600 mg over a 90-day period in 100 subjects. At this dose, the study demonstrated a 38.08% reduction in KOOS pain score and a 34.31% reduction in WOMAC stiffness. This dosing provides a clinically validated reference point for brands developing joint comfort and active lifestyle formulations, though the recommended dosage in a finished product may vary based on the specific indication and format.
What certifications does Boswegex® hold?
Boswegex® is manufactured in a 100% solar-powered facility certified for NSF-GMP (Good Manufacturing Practice), HACCP (Hazard Analysis and Critical Control Points), and ISO 9001. The product is also Kosher and HALAL certified, and is produced using patented green manufacturing technology and verified by HPLC. Full documentation, including certificates of analysis and safety data sheets, is available on request.
Who manufactures Boswegex® and how is it produced?
Boswegex® is manufactured by Ingex Botanicals (P) Limited in India, the manufacturing arm of Ingex Germany GmbH, from the resin of Boswellia serrata. It is produced using patented green manufacturing technology in a 100% solar-powered facility certified for GMP, HACCP, and ISO 9001, and verified by HPLC. It is then warehoused at our Rotterdam, Netherlands facility and supplied to European nutraceutical and supplement brands through Ingex Germany, with full batch traceability and EU-ready documentation maintained at every stage.
Do you hold Boswellia extract stock in Europe?
Yes. As a dedicated Boswellia extract supplier in Europe, we maintain stock of Boswegex® at our warehouse in Rotterdam, Netherlands. This allows us to offer fast, reliable delivery to customers across the EU, including Germany, France, Italy, Spain, the Benelux countries, and beyond, without the delays of direct shipping from Asia. Contact us to check current stock availability and lead times.
Who is Boswegex® Boswellia extract suitable for?
Boswegex® is designed for B2B customers in the nutraceutical, dietary supplement, and functional food industries. It is suitable for supplement manufacturers, contract formulators, private label brands, and sports nutrition developers looking for a clinically proven, full-spectrum joint health ingredient. Boswegex® is ideal for joint comfort capsules, mobility tablets, healthy aging formulas, and active lifestyle supplement formulations.
Get in Touch

Ready to Partner with Us?

Request a sample, bulk quote, or technical documentation for Boswegex® Boswellia extract. Our team responds within one business day.

Or write to us at: enquiry@ingexgermany.de